Hong Deng

Summary

Affiliation: Sun Yat-sen University
Country: China

Publications

  1. ncbi [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients]
    Hong Deng
    Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 14:721-4. 2006
  2. ncbi [A pilot study of peginterferon alfa-2a combined with short-term lamivudine therapy in HBeAg-positive chronic hepatitis B patients]
    Zhan Lian Huang
    Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 18:419-22. 2010
  3. ncbi [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B]
    Dong ying Xie
    Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 18:646-50. 2010

Collaborators

  • Dong ying Xie
  • Zhan Lian Huang
  • Zhi Liang Gao
  • Xiao Hong Zhang
  • Yu Tian Chong
  • Cui Rong Lu
  • Feng juan Chen
  • Bing Liang Lin
  • Yu feng Zhang
  • Zhi xin Zhao

Detail Information

Publications3

  1. ncbi [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients]
    Hong Deng
    Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 14:721-4. 2006
    ....
  2. ncbi [A pilot study of peginterferon alfa-2a combined with short-term lamivudine therapy in HBeAg-positive chronic hepatitis B patients]
    Zhan Lian Huang
    Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 18:419-22. 2010
    ..To investigate the efficacy of by combining a 12-week course of lamivudine in those HBeAg-positive hepatitis B patients receiving peginterferon alfa-2a (peg-IFN alpha-2a) therapy...
  3. ncbi [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B]
    Dong ying Xie
    Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat Sen University, Guangzhou 510630, China
    Zhonghua Gan Zang Bing Za Zhi 18:646-50. 2010
    ..To study PD-1 and PD-L1 expressions during 24 weeks telbivudine antiviral treatment in patients with chronic hepatitis B (CHB) and to explore the relationship between PD-1 expression and HBeAg/HBeAb seroconversion...